For decades, formalin-fixing paraffin-embedding has been the preferred method for preserving biological samples for diagnostic research. Formalin is relatively inexpensive and can be used to preserve ...
The discipline of genomics has experienced an unprecedented revolution, boosting the understanding of health and illness and promoting the creation of customized medicine for better therapeutic ...
Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic non-small cell lung cancer. Utilizing TP53 mutation status and initial disease burden at presentation to ...
The youngest population under 50 years old (P50) with lung cancer (LC) in the French nationwide real-life KBP cohorts: Evolution since 2000. Clinical outcomes of maintenance durvalumab after ...
Both Sanger sequencing and next-generation sequencing (NGS) are powerful tools for genomic analysis that are commonplace in labs around the world. Choosing the best technique is important and will ...
Understanding Bioinformatics Workflows for NGS Analysis: Case Study with Whole-exome Sequencing Data
NGS enables the in-depth analysis of the genome and the identification and investigation of disease-associated variants–especially when workflows include target enrichment, which focuses on specific ...
The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...
In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...
Tired of multi-stage genotyping workflows that slow down your sequencing projects? This high-throughput, one-step genotyping by sequencing method delivers accurate, reproducible data across species ...
Different applications have different requirements, so researchers need to carefully weigh their options when deciding whether to switch to a new platform. [© WavebreakmediaMicro – Fotolia.com] With ...
In the United States, healthcare professionals classify a disease as rare if it affects fewer than 200,000 individuals. As of August 7, 2024, the U.S. population consists of just under 336.9 million ...
SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics, a genetic testing laboratory on the forefront of bringing physicians a broad genetic testing portfolio covering a wide range of diseases, announces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback